IndyCar series canceling all races before Month of May in Indy
There were four events on the series’ 2020 schedule before action was set to return to Indianapolis Motor Speedway.
Diseases
Articles
Gov. Holcomb bans gatherings of 250 or more, makes it easier for schools to close
“This is a time when we must do all we can to reduce the spread of COVID-19, protect our most vulnerable populations and reduce their potential to acquire or spread this virus,” Holcomb said in a statement. “While some actions are drastic, now, not later, is the time to act.”
State total of COVID-19 cases rises to 12 after two more positive tests
The department said it had tested 64 Hoosiers for the virus. No deaths have been reported.
Indiana hospitals use drills, telehealth to get ready for possible large COVID-19 outbreak
Around Indiana, hospital officials say they have stepped up safety precautions in the wake of the COVID-19 outbreak. But even amid extensive preparation, some acknowledge that if the disease spreads quickly, it could test their facilities.
One of city’s largest law firms closes offices amid coronavirus concerns
No staff members or lawyers at Faegre Drinker Biddle & Reath had tested positive for COVID-19, but a person who attended a firm event in Faegre Drinker’s Washington office had tested positive. Employees are now working remotely.
Hendricks County elementary school student has positive COVID-19 test, school district says
This is the third reported positive test for COVID-19 in Indiana, and the second in Hendricks County.
U.S. coronavirus fatality rate could be lower than global rate so far
Evidence is mounting that the disease is most likely to result in serious illness or death among the elderly and people with existing health problems.
In surprise turnaround, new analysis finds Alzheimer’s treatment might work
Seven months after clinical trials for a promising Alzheimer’s drug were halted and the treatment was declared a failure, a new analysis suggests it was actually effective, and the company that makes it plans to move forward in securing federal approval.
IU Simon Cancer Center lands $13.8M grant, comprehensive cancer center designation
The cancer center, opened in 2008, is now one of just 51 “comprehensive cancer centers” in the nation and the only one in Indiana.
U.S. Sen. Todd Young, others fight for progress on smoking
Young is out front nationally on a key anti-smoking platform: Raising the minimum age for buying tobacco to 21.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
Pfizer expanding in cancer with $10.6B deal for Array BioPharma
Array’s stock was already at a record before the deal announcement, following the company’s news last month of positive clinical trial results using Braftovi and Mektovi with Indianapolis-based Eli Lilly and Co.’s Erbitux.
Bristol-Myers gets shareholder approval for $74B Celgene deal
Bristol-Myers Squibb Co. on Friday won a shareholder vote to approve its takeover of Celgene Corp., paving the way to close the largest pharmaceutical merger in history and create a cancer-drug giant.
Marion County syringe-exchange program ready to hit the road
County officials unveiled a mobile health unit that will visit neighborhoods hit hard by hepatitis C and offer health screenings and clean needles in the latest tactic against the opioid epidemic.
Indy startup Outpost Medicine draws in big money to develop drug therapies
For a startup that has raised an eye-popping $71 million in just three years, Outpost Medicine LLC likes to keep a low profile. The young company, which is developing drugs for urinary and gastrointestinal disorders, is headquartered in small, unmarked space at the Parkwood Crossing office complex on East 96th Street. It has issued only a […]
Harvard study involving Anthem unit finds older insulins are both safe, cheaper
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Lilly cancer drug shouldn’t be started in new patients, FDA says
Lartruvo shouldn’t be started in new patients, and those patients already taking it should ask their doctors if they should continue, U.S. regulators said, following a key study that failed to show the medicine prolonged lives.
U.S. cancer death rate hits 25th year of decline
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
Two IU researchers win $2.3M grant to study neuropathy in cancer patients
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.